New drug combo could slash pregnancy risks from malaria
NCT ID NCT04336189
First seen Nov 06, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This study tested whether giving pregnant women a combination of two malaria drugs (sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine) every 4 weeks works better than either drug alone to prevent serious birth problems. Over 2,700 HIV-negative pregnant women in Uganda took part. The goal was to see if the combo could lower the risk of miscarriage, stillbirth, low birth weight, preterm birth, and newborn death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Infectious Diseases Research Collaboration Clinic - Masafu Hospital
Masafu, Busia, Uganda
Conditions
Explore the condition pages connected to this study.